HYMPAVZI: payments to doctors
Payments that named HYMPAVZI as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $481K
- Providers
- 866
- Transactions
- 1,560
- Average per transaction
- $308
The per-transaction average — $308 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 866 providers the average total is $556, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Pfizer | $479,175 | 99.6% |
| PBG Puerto RICO LLC | $2,031 | 0.4% |